ATE6065T1 - Verfahren zur herstellung von thienamycin und zwischenprodukten. - Google Patents

Verfahren zur herstellung von thienamycin und zwischenprodukten.

Info

Publication number
ATE6065T1
ATE6065T1 AT79101307T AT79101307T ATE6065T1 AT E6065 T1 ATE6065 T1 AT E6065T1 AT 79101307 T AT79101307 T AT 79101307T AT 79101307 T AT79101307 T AT 79101307T AT E6065 T1 ATE6065 T1 AT E6065T1
Authority
AT
Austria
Prior art keywords
chem
hydrogen
thienamycin
protecting group
production
Prior art date
Application number
AT79101307T
Other languages
English (en)
Inventor
Burton Grant Christensen
Thomas Norse Salzmann
Ronald William Ratcliffe
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/933,323 external-priority patent/US4174316A/en
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Application granted granted Critical
Publication of ATE6065T1 publication Critical patent/ATE6065T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C07D477/04—Preparation by forming the ring or condensed ring systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT79101307T 1978-08-14 1979-05-01 Verfahren zur herstellung von thienamycin und zwischenprodukten. ATE6065T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/933,323 US4174316A (en) 1978-08-14 1978-08-14 4-Iodomethylazetidin-2-one
EP79101307A EP0007973B1 (de) 1978-08-14 1979-05-01 Verfahren zur Herstellung von Thienamycin und Zwischenprodukten

Publications (1)

Publication Number Publication Date
ATE6065T1 true ATE6065T1 (de) 1984-02-15

Family

ID=26077680

Family Applications (2)

Application Number Title Priority Date Filing Date
AT82105683T ATE17574T1 (de) 1978-08-14 1979-05-01 Zwischenprodukte zur herstellung von thienamycin und verfahren zu ihrer herstellung.
AT79101307T ATE6065T1 (de) 1978-08-14 1979-05-01 Verfahren zur herstellung von thienamycin und zwischenprodukten.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT82105683T ATE17574T1 (de) 1978-08-14 1979-05-01 Zwischenprodukte zur herstellung von thienamycin und verfahren zu ihrer herstellung.

Country Status (3)

Country Link
EP (1) EP0066301B1 (de)
AT (2) ATE17574T1 (de)
DE (1) DE2967572D1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6253994A (ja) 1985-05-09 1987-03-09 Yamanouchi Pharmaceut Co Ltd １−置換シリル−４−オキソ−２−アゼチジンカルボン酸低級アルキルエステル

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4122086A (en) * 1977-07-26 1978-10-24 Smithkline Corporation Isopenicillins

Also Published As

Publication number Publication date
EP0066301B1 (de) 1986-01-22
ATE17574T1 (de) 1986-02-15
DE2967572D1 (en) 1986-03-06
EP0066301A1 (de) 1982-12-08

Similar Documents

Publication Publication Date Title
ATE58896T1 (de) Neue zwischenprodukte und verfahren zur herstellung von 3-acylamino-1-hydroxy-2azetidinonen.
ATE145891T1 (de) Verfahren zur herstellung von alkoxyiminoacetamid-derivaten und ein zwischenproduckt dafür
ATE87925T1 (de) Erythromycin-a-derivate und verfahren zu ihrer herstellung.
ATE35417T1 (de) Verfahren zur herstellung von phosphorhaltigen cyanhydrinderivaten.
ATE60060T1 (de) Sialosylceramide und verfahren zu deren herstellung.
DE69707341D1 (de) Verfahren zur Herstellung von 4-Aryl-3-Hydroxymethyl-piperidinen
ATE10372T1 (de) Synisomer von cephalosporinverbindungen und verfahren zu ihrer herstellung.
ATE6065T1 (de) Verfahren zur herstellung von thienamycin und zwischenprodukten.
PT79118A (de) Cephalosporinderivate und verfahren zur ihrer herstellung
ATE10277T1 (de) Verfahren zur herstellung von heterozyklylalkylguanidinen, zwischenprodukte und deren herstellung.
ATE34977T1 (de) Verfahren zur herstellung von cholecalciferolderivaten.
ATE46322T1 (de) Verfahren zur herstellung von bestatin-derivaten und deren zwischenprodukte.
ATE28749T1 (de) Verfahren zur herstellung von 3,4-dihydro-alpha- pyronen.
DE69800073D1 (de) Verfahren zur Herstellung von 2-Cyanobiphenyl-Verbindungen
DE69332707D1 (de) Verfahren zur Herstellung von 3-Vinylcephalosporinen
HUT34439A (en) Pesticides consisting of n-sulphenilized phenethil sulphonamids and process for production of the compounds
ES8200092A1 (es) Procedimiento para la sintesis de esteres de la n-(4'hidro- xifenil) acetamida con acidos 5-benzoil-1-metilpirrol-2-ace-tico
DE69223016D1 (de) Verfahren und Zwischenprodukte für die Herstellung von 6-Fluorbenzisothiazolen
ATE18901T1 (de) Zwischenprodukte zur herstellung von 4-phenyl-1,3-benzodiazepinen und verfahren zur herstellung dieser zwischenprodukte.
SE7503560L (de)
ATE135693T1 (de) Halogeno-4-methylpyrazole und verfahren zu ihrer herstellung
DE3473269D1 (en) (bis(substituted methyl)-methyl)-isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them
ATE18194T1 (de) Verfahren zur herstellung von carbonsaeureanhydriden.
ATE17240T1 (de) Verfahren und zwischenprodukte zur herstellung von benzothiazincarboxamiden.
ATE16696T1 (de) Verfahren zur herstellung von 3-alkyl-6-methylbeta-resorcylsaeureestern.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification